Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting

MISSISSAUGA, ON, May 11, 2017 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI) a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that at its 2017 Annual and Special Meeting of Shareholders held in Toronto, all nominees listed in the management proxy circular dated April 5, 2017 were elected as directors of the Company.

The detailed results of the votes by proxy are as follows:

Director Nominees

NUMBER OF SHARES

PERCENTAGE OF VOTES CAST

FOR

WITHHELD

FOR

WITHHELD

Daniel Chicoine

2,997,859

82,678

97.32

2.68

David A. Copeland

2,999,892

80,645

97.38

2.62

Anthony E. Dobranowski

3,002,978

77,559

97.48

2.52

Robert Harris

3,011,591

68,946

97.76

2.24

John C. London

2,999,920

80,617

97.38

2.62

Dr. Jacques Messier

2,999,298

81,239

97.36

2.64

 

About Nuvo Pharmaceuticals Inc.
Nuvo (TSX:NRI) is a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities. Nuvo has three commercial products that are available in a number of countries; Pennsaid 2%, Pennsaid and the heated lidocaine/tetracaine patch.  Pennsaid 2% is sold in the U.S. by Horizon Pharma plc (NASDAQ: HZNP) and is available for partnering in certain other territories around the world. Nuvo manufactures Pennsaid for the global market and Pennsaid 2% for the U.S. market at its FDA, Health Canada and E.U. approved manufacturing facility in Varennes, Québec. For additional information, please visit www.nuvopharmaceuticals.com.

SOURCE Nuvo Pharmaceuticals Inc.

For further information: Investor Relations, Email: ir@nuvopharm.com

RELATED LINKS
nuvopharmaceuticals.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890